Recent Quotes
My Watchlist
Indicators
Local Stocks
Buffalo Local Index
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Simulations Plus Inc (NQ: SLP )

63.67 USD UNCHANGED
Streaming Delayed Price Updated: 5:05 PM EDT, Apr 15, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Simulations Plus Inc

< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Simulations Plus Reports Record Second Quarter Fiscal 2021 Financial Results
Simulations Plus today reported record 2nd quarter results for FY2021. Net revenue of $13.1 million, up 27% over 2QFY20; YTD revenue of $23.8 million. 
From Business Wire News Releases
Simulations Plus Reports Successful Results from AIDD Collaboration with Large Pharmaceutical Company
Simulations Plus reports excellent results from its Artificial Intelligence-driven Drug Design (AIDD) module in ADMET Predictor in testing by partner. 
From Business Wire News Releases
Simulations Plus Sets Date for Second Quarter Fiscal Year 2021 Earnings Release and Conference Call
Simulations Plus announced today that it will report its 2nd quarter fiscal year 2021 results on Monday, April 12, 2021, with a webcast at 4:15 pm ET. 
From Business Wire News Releases
Simulations Plus Forms Scientific Advisory Board for RENAsym Consortium
Simulations Plus announced the formation of a Scientific Advisory Board to guide the development of its RENAsym QST kidney injury software platform. 
From Business Wire News Releases
Simulations Plus Hosts the Inaugural 2021 MIDD+ Scientific Conference with over 50 Model-Informed Drug Development Sessions
Simulations Plus announced the successful launch of its 2021 MIDD+ Scientific Conference with speakers from industry, academia, & regulatory agencies. 
From Business Wire News Releases
Simulations Plus to Present at Oppenheimer Healthcare Conference
Simulations Plus CEO Shawn O'Connor will present at Oppenheimer's 31st Annual Healthcare Conference on March 16, 2021, beginning at 2:30 p.m. ET. 
From Business Wire News Releases
Simulations Plus and the University of Pittsburgh Drug Discovery Institute Receive SBIR Grant Funding for Large Molecule Safety Collaboration
Simulations Plus announced that its DILIsym division and the University of Pittsburgh Drug Discovery Institute jointly received a Phase I SBIR grant. 
From Business Wire News Releases
Simulations Plus to Participate in BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference
Simulations Plus will host fireside chat at BTIG's Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference on Feb. 18, at 12pm ET. 
From Business Wire News Releases
Simulations Plus Releases GastroPlus® Version 9.8.1
Simulations Plus today announced the release of GastroPlus 9.8.1 with key enhancements to improve efficiency and inform regulatory decision making. 
From Business Wire News Releases
Simulations Plus Enters Agreement with Distributor in China
Simulations Plus today announced an agreement to distribute Lixoft's MonolixSuite in China with Mosim, one of China's leading clinical CROs. 
From Business Wire News Releases
Simulations Plus Expands Marketing and Sales Operations in South America Through Partnership with the Institute of Pharmaceutical Sciences
Simulations Plus today announced that it is partnering with the Institute of Pharmaceutical Sciences (ICF) in Brazil, to expand into South America. 
From Business Wire News Releases
NASDAQ:SLP Investor Alert: Investigation over Potential Wrongdoing at Simulations Plus, Inc.
San Diego, CA -- (SBWIRE) -- 01/25/2021 -- An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Simulations Plus, Inc. 
From SBWire - Latest Press Releases
Simulations Plus Awards Infrastructure Improvement Grant to Makerere University Department of Pharmacology and Therapeutics
Simulations Plus today announced that it has awarded a grant to Uganda's Makerere University funding upgraded infrastructure to facilitate research. 
From Business Wire News Releases
Simulations Plus to Present at 23rd Annual Needham Virtual Growth Conference
Simulations Plus announced that CEO Shawn O'Connor will present at the 23rd Annual Needham Virtual Growth Conference on January 14, 2021, at 2pm ET. 
From Business Wire News Releases
Simulations Plus Enters New Funded Collaboration to Improve Lung Exposure Models for Pulmonary Infection Treatments
Simulations Plus today announced a new funded collaboration with a large pharmaceutical partner to enhance PBPK/PD models for pulmonary therapeutics. 
From Business Wire News Releases
Simulations Plus Reports Record First Quarter FY2021 Financial Results
Simulations Plus today reported record 1st quarter results for FY2021. Net revenues of $10.7 million increased 14%; net income was up 21% over 1QFY20. 
From Business Wire News Releases
Simulations Plus Enters New Funded Collaboration to Enhance Top-Rated GastroPlus® ACAT™ Model for Oral Absorption of Peptides
Simulations Plus today announced a new funded collaboration to enhance its GastroPlus ACAT model with novel mechanisms for oral peptide formulations. 
From Business Wire News Releases
Simulations Plus Sets Date for First Quarter Fiscal Year 2021 Earnings Release and Conference Call
Simulations Plus announced today that it will report its first quarter fiscal year 2021 results on Monday, Jan. 11, 2021, with a webcast at 4:15 pm ET 
From Business Wire News Releases
Simulations Plus Publishes its Inaugural Environmental, Social and Governance (ESG) Report
Simulations Plus today announced that it has published its inaugural Environmental, Social and Governance (ESG) report on its website's Investors page 
From Business Wire News Releases
DILIsym Services Presents Important DILIsym and NAFLDsym Software Applications at the Virtual AASLD Liver Meeting
DILIsym Services, a Simulations Plus company, announced today that vital applications of their software were presented at the 2020 AASLD Liver Meeting 
From Business Wire News Releases
Simulations Plus Names Industry Veteran Will Frederick as Chief Financial Officer
Simulations Plus today announced the appointment of Will Frederick as CFO, succeeding John Kneisel who is retiring after 7 years with the Company. 
From Business Wire News Releases
Simulations Plus Reports FY2020 and Fourth Quarter FY2020 Financial Results
Simulations Plus today reported results for the 4th quarter and fiscal year 2020. Full FY20 revenues increased 22.4%; 4QFY20 revenues increased 18.9%. 
From Business Wire News Releases
DILIsym Plays Critical Role in Submission to State of California for Common Analgesic Carcinogenicity Risk Assessment
DILIsym Services, an SLP company, announced today that DILIsym modeling results of APAP are cited in public comments submitted to California's OEHHA. 
From Business Wire News Releases
Simulations Plus Sets Date for 4th Quarter and Fiscal Year 2020 Earnings Release and Conference Call
Simulations Plus announced today that it will report its 4th quarter and fiscal year 2020 results on Mon., Nov. 16, 2020, with a webcast at 4:15 pm ET 
From Business Wire News Releases
Simulations Plus to Participate in the Credit Suisse Virtual Healthcare Conference
Simulations Plus announced today that CEO Shawn O'Connor will be participating in the Credit Suisse Virtual Healthcare Conference on Nov. 10, 2020. 
From Business Wire News Releases
Lixoft Expands MonolixSuite™ in Version 2020R1
Lixoft, an SLP company, announced today the release of MonolixSuite 2020R1 with key advancements in simulations for clinical trial pharmacometrics. 
From Business Wire News Releases
First Approved Cancer Treatment for TGCT Included DILIsym Simulations in FDA Review
DILIsym Services, an SLP company, announced today that analysis with DILIsym software was cited in the FDA review of Turalio®, approved to treat TGCT. 
From Business Wire News Releases
Simulations Plus Releases GastroPlus® Version 9.8
Simulations Plus today announced the release of GastroPlus 9.8 with key improvements to non-oral delivery models, virtual bioequivalence, and DDIs. 
From Business Wire News Releases
Simulations Plus Teams Up with the University of Health Sciences and Pharmacy in St. Louis to Secure New Grant Award from the U.S. FDA
Simulations Plus today announced a new collaboration with the FDA & St. Louis College of Pharmacy to develop novel oral cavity models in GastroPlus. 
From Business Wire News Releases
Simulations Plus Announces Quarterly Cash Dividend of $0.06 per Share
Simulations Plus announced today that its Board of Directors has declared a cash dividend of $0.06 per share to be distributed on Nov. 2, 2020. 
From Business Wire News Releases
< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.